CannaPharmaRx Inc
OTC:CPMD
CannaPharmaRx Inc
OTC:CPMD
Price:
0.0038
USD
22.58%
Market Closed
Market Cap:
$2.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
CannaPharmaRx Inc
OTC:CPMD
|
CA |
|
F
|
Ferrari NV
LSE:0RDT
|
IT |
|
G
|
GEA Group AG
XHAM:G1A
|
DE |
|
Macbee Planet Inc
TSE:7095
|
JP |
|
LifeWorks Inc
TSX:LWRK
|
CA |
|
Riken Vitamin Co Ltd
TSE:4526
|
JP |
|
Paris Miki Holdings Inc
TSE:7455
|
JP |
|
S
|
Shin Heung Energy & Electronics Co Ltd
KOSDAQ:243840
|
KR |
|
L
|
L&P Global Bhd
KLSE:L&PBHD
|
MY |
|
T
|
Trisula Textile Industries Tbk PT
IDX:BELL
|
ID |
|
Medesis Pharma SA
PAR:ALMDP
|
FR |
|
SPC Nickel Corp
XTSX:SPC
|
CA |
|
Tokyo Ichiban Foods Co Ltd
TSE:3067
|
JP |
|
iRhythm Technologies Inc
NASDAQ:IRTC
|
US |
|
B
|
Beijing Enterprises Environment Group Ltd
HKEX:154
|
HK |
|
Top Education Group Ltd
HKEX:1752
|
AU |
|
Juki Corp
TSE:6440
|
JP |
|
I
|
Isu Specialty Chemical Co Ltd
KRX:457190
|
KR |
|
Phoenix Global Resources PLC
LSE:PGR
|
UK |
|
Cesar SA
PAR:ALCES
|
FR |
|
P
|
Petsec Energy Ltd
ASX:PSA
|
AU |
|
Synovus Financial Corp
NYSE:SNV
|
US |
|
Singaraja Putra Tbk PT
IDX:SINI
|
ID |
Multiples-Based Value
The Multiples-Based Value of one
CPMD
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 0.0038 USD,
CannaPharmaRx Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CPMD Multiples-Based Value
LOCKED
Multiples Across Competitors
CPMD Competitors Multiples
CannaPharmaRx Inc Competitors
CannaPharmaRx Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
CannaPharmaRx Inc
OTC:CPMD
|
2.5m USD | 1.8 | -0.2 | -3.3 | -3.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
871.6B USD | 13.4 | 42.2 | 28.5 | 30.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.1B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
231.4B GBP | 5.2 | 30 | 16.6 | 23.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.9B USD | 4.6 | 16.3 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.4B CHF | 5.1 | 20.7 | 12.8 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.7 | 11.1 | 8.2 | 9.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
89.3B GBP | 2.7 | 15.6 | 8.4 | 10.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
